{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small Cell Lung Cancer","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-2-open-label-parallel-cohort-study-of-subcutaneous-amivantamab-in-multiple-regimens-in-patients-with-advanced-or-metastatic-solid-tumors-including-egfr-mutated-non-small-cell-lung-cancer\/#breadcrumbitem"}]}